Industry Insights

Home » Industry Insights
2403, 2017

Trump’s Proposed Health Budget Cuts Will be Disastrous for Science, Healthcare & Patients, Says ISCT

By |March 24th, 2017|Categories: Market insights, News, Pharmaceutical|Tags: |0 Comments

The International Society of Cellular Therapy (ISCT) believes that the massive and unprecedented budget cuts to US governmental scientific agencies including the NIH (National Institutes of Health) and NSF (National Science Foundation) proposed by US President Trump, if implemented, will have wide ranging and potentially life [...]

2403, 2017

Cobra Biologics Wins CMO Leadership Award in Five Categories

By |March 24th, 2017|Categories: News, Outsourcing, Pharmaceutical|Tags: |0 Comments

Cobra Biologics Ltd, an international CDMO of biologics and pharmaceuticals, has been recognised with a CMO Leadership Award 2017 in the five categories Quality, Reliability, Capabilities, Expertise and Compatibility. Presented at a reception dinner at [...]

2403, 2017

FDA Approves Xadago (Safinamide) for Parkinson’s Disease Patients

By |March 24th, 2017|Categories: News, Pharmaceutical, Regulatory Affairs|Tags: , , |0 Comments

Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, and its partners Zambon SpA and US WorldMeds, have announced that [...]

2403, 2017

Verona Pharma Enters Global Strategic Clinical Development Services Agreement with QuintilesIMS for RPL554

By |March 24th, 2017|Categories: Business and Finance, News, Pharmaceutical|Tags: , |0 Comments

Verona Pharma, a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs, has entered into a global strategic services agreement with QuintilesIMS, a [...]

2303, 2017

ASLAN Pharmaceuticals Wins Inaugural BioSingapore Innovative Biomedical Company Award

By |March 23rd, 2017|Categories: Business and Finance, News, Pharmaceutical|Tags: |0 Comments

ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents for Asia-prevalent tumour types, has announced that it has won the inaugural BioSingapore Innovative Biomedical Company award. The award, presented by BioSingapore, [...]

2303, 2017

Helsinn Collaborates with Lyfebulb to Support Patient-Driven Innovations for People with Cancer

By |March 23rd, 2017|Categories: News, Pharmaceutical, Research and Development|Tags: , |0 Comments

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care announces a collaboration with Lyfebulb, a patient-centric company that empowers patient entrepreneurs to deliver innovative products and solutions to patients living with chronic disease.  [...]